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The objective of this study was to investigate the feasibility of a speciﬁc custom-made 
fenestrated aortic cuff in the treatment of complex abdominal aortic aneurysms (AAAs).
Between 2013 and 2016, a total of 57 custom-made Fenestrated Anaconda (Vascutek, 
Inchinnan, Scotland, UK) aortic cuffs were placed in 38 centers worldwide. All centers were 
invited to participate in this retrospective analysis. Postoperative and follow-up data included 
the presence of adverse events, necessity for reintervention, and renal function.
Fifteen clinics participated, leading to 29 cases. Median age at operation was 74 years (in-
terquartile range [IQR], 71-78 years); ﬁve patients were female. Two patients were treated 
for a para-anastomotic AAA after open AAA repair, 19 patients were treated because of a 
complicated course after primary endovascular AAA repair, and 8 cases were primary 
procedures for AAA. A total of 76 fenestrations (mean, 2.6 per case) were used. Four patients 
needed seven adjunctive procedures. Two patients underwent conversion, one because of a 
dissection of the superior mesenteric artery and one because of perforation of a renal artery. 
Median operation time was 225 minutes (IQR, 150-260 minutes); median blood loss, 200 
mL (IQR, 100-500 mL); and median contrast volume, 150 mL (IQR, 92-260 mL). Primary 
technical success was achieved in 86% and secondary technical success in 93%. The 30-day 
morbidity was 7 of 29 with a mortality rate of 4 of 29. Estimated glomerular ﬁltration rate 
remained unchanged before and after surgery (76 to 77 mL/min/m2). Between preopera-
tive and median follow-up of 11 months, estimated glomerular ﬁltration rate was reduced 
statistically signiﬁcantly (76 to 63 mL/min/m2). During follow-up, 9 cases had an increase 
in aneurysm sac diameter (5 cases >5 mm); 14 cases had a stable or decreased aneurysm sac 
diameter; and in 2 cases, no aneurysm size was reported. No type I endoleak was reported, 
and two cases with a type III endoleak were treated by endovascular means during follow-up. 
Survival, reintervention-free survival, and target vessel patency at 1 year were 81%±8%, 
75%±9%, and 99%±1%, respectively. After 2 years, these numbers were 81%±8%, 67%±11%, 
and 88%±6%, respectively. During follow-up, the two patients with a type III endoleak needed 
endograft-related reinterventions. 
Treatment with this speciﬁc custom-made fenestrated aortic cuff is feasible after complicated 
previous (endovascular) aortic repair or in complex AAAs. The complexity of certain AAA 
cases is underlined in this study, and the Fenestrated Anaconda aortic cuff is a valid option in 
selected cases in which few treatment options are left.
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Introduction
For decades, the treatment of an abdominal aortic aneurysm (AAA) consisted of open 
repair through laparotomy. During follow-up after open repair, a proximal paraanasto-
motic aneurysm may develop, which occurs in up to  3%.1  Once  it  has  developed,  the 
rupture  risk  is between 15% and 55%.2 Open redo surgical treatment of an extended AAA 
has a procedural mortality of 14% in asymptomatic patients.2 Endovascular aneurysm repair 
(EVAR) has emerged as a viable alternative in proximal para-anastomotic AAA, without 
reported procedural mortality and an annual reintervention risk of 17%.3
EVAR has favorable early results over open AAA repair in primary cases but is associated 
with a higher reintervention rate in the long term because of endoleak, migration, and device 
failure.4-7 A short, conical, and angulated infrarenal aortic neck increases the chance   of type 
IA endoleak and endograft migration.8-10 Subsequently, it may lead to AAA sac expansion and 
rupture.11
In primary AAA or thoracoabdominal aneurysm (TAA) cases with a narrow or otherwise 
healthy distal aorta, a bifurcated or uni-iliac endograft might not be the most suitable.
All three entities, proximal para-anastomotic aneurysm, complicated EVAR, and primary 
Figure 1: Left-anterior view of the custom-made Fenestrated 
Anaconda™ cuff with two fenestrations and fully augmented 
proximal ring configuration. The stitching on the left peak hook 
indicates the location of the proximal ring hook markers. Permission 
for use granted by Vascutek Ltd. Inchinnan, Scotland, UK.
cases, could be treated with an aortic cuff. The length 
of the remaining infrarenal sealing zone may be a 
problem, with placement of the cuff near the level of 
the visceral arteries potentially overstenting these 
arteries.12,13 Placement of a fenestrated aortic device, 
possibly combined with thoracic endovascular aortic 
repair (TEVAR), could overcome overstenting of 
visceral arteries in an overly short neck.
Previous cases with the Zenith fenestrated cuff (Cook 
Medical, Bloomington, Ind) appeared to be successful 
after failed EVAR, but there were restrictions in 







(Inchinnan, Scotland, UK) developed the custom-made Fenestrated Anaconda aortic cuff 
(Figure 1), applicable in more angulated necks up to 90 degrees compared with the 60-degree 
angulated neck limitation with the Zenith fenestrated cuff.16
No results have been reported yet for the Fenestrated Anaconda cuff, but the design potentially 
leads to higher technical success for patients with complex aortic anatomy. This study investi-
gated the feasibility of the Fenestrated Anaconda aortic cuff for complex AAA repair.
Methods
Design 
Between 2013 and 2016, a total of 57 patients in 38 European hospitals were treated with the 
Fenestrated Anaconda cuff for a proximal para-anastomotic aneurysm after failed EVAR or 
as primary treatment, and all were eligible for inclusion. An aortic cuff in primary treatment 
could be used solely in case of a narrow distal aorta or as part of TAA repair. All treatment sites 
were asked to participate in this retrospective study. Patients were excluded if they underwent 
implantation of an aortic uni-iliac or bi-iliac endograft. 
Retrospective research of patients’ ﬁles is not under the scope of the Dutch Act on Medical 
Scientiﬁc Research Involving Human Beings (WMO). The Institutional Review Board 
approved the protocol, data collection, and study design (M16.200104); therefore, informed 
consent of the patients was not required. The manufacturer provided a list of clinics, without 
patient information, where Fenestrated Anaconda cuffs were implanted. Once participating, 
patients’ data were retrospectively collected by the treating clinician and ﬁlled into an online 
case report form without any patient-identiﬁable information (OpenClinica, version 3.11; 
OpenClinica LLC, Waltham, Mass). Data were analyzed anonymously by the investigators. 
Data collection. Patients’ comorbidities were gathered, speciﬁcally cardiac, pulmonary, and 
renal disease and American Society of Anesthesiologists (ASA) class.17 The patient’s clinician 
assessed the AAA anatomy by multi-slice spiral computed tomography angiography (CTA), 
and a neck was considered short when an infrarenal length   from   lowest   renal   artery   to 
aneurysm was <10 mm and infrarenal sealing would be insufﬁcient. Measurements included 
landing zone angulation, deﬁned straight in 0 degrees, counting toward 90 degrees in more 
angulation. 
Information about the operation was gathered for type of anesthesia, type and location of 
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access, operation time, contrast material volume, estimated blood loss, successful cannulation 
of target vessels, operative mortality and morbidity, and procedural technical success. 
Procedural primary technical success was deﬁned as an exclusion of the aneurysm, deployment 
of the planned endograft, and successful stenting of target vessels but without type I or type 
III endoleak at completion angiography and without conversion or mortality within 24 hours 
of surgery. In case an unplanned procedure was successfully performed, technical success was 
deﬁned as a secondary technical success.18 Postoperative information was gathered during the 
30-day postoperative period and follow-up, including laboratory ﬁndings, duplex ultrasound 
or CTA, target vessel patency, endoleak, and reinterventions. 
Technical details 
The cuff was designed by Vascutek and customized to the patient according to preoperative 
CTA measurements. The Fenestrated Anaconda endograft is typically oversized 10% to 25%, 
depending on landing zone angulation. The design’s proximal and distal diameters typically 
vary between 19 and 34 mm, with a length up to 120 mm. The endograft consists of two 
proximal nitinol rings that default to their single-plane conﬁguration, and oversizing creates 
two opposing valleys and peaks apposing the aortic wall. These rings contain three or four 
pairs of hooks to attach to the aortic wall. In standard design, the rings are parallel; but by 
converging the rings from dorsal to anterior, placement is allowed between a proximal celiac 
artery and superior mesenteric artery (SMA), still enabling adequate sealing. 
Below the proximal rings, the unsupported part can theoretically hold an unlimited number 
of nitinol-reinforced fenestrations.19 The implantation procedure has been described in more 
detail before.19
Data analysis
Discrete variables were presented with frequencies and percentages. Continuous variables 
were presented with median and interquartile range (IQR) because of the small sample size, 
and Wilcoxon signed rank test was used. Overall survival, reintervention rate, and target 
vessel patency were subjected to Kaplan-Meier analysis. Survival analysis conﬁdence interval 
was taken at  95%,  and  statistical  signiﬁcance  was  set  at P < .05. SPSS (version 22; IBM 









Fifteen clinics composing the Fenestrated Anaconda Cuff Study Group agreed to participate, 
resulting in 29 cases. Fenestrated Anaconda cuffs were implanted in six clinics in one patient, 
in another six clinics in two patients, in two clinics in three patients, and in one clinic in ﬁve 
patients. The remaining 28 cases were performed in 23 clinics that did not respond or did not 
want to participate.
TABLE I: PREOPERATIVE CHARACTERIS-
TICS OF PATIENTS TREATED WITH THE 











Cardiac disease 14/29 (48)
CVD 4/29 (14)
Renal disease 9/29 (31)
Dialysis dependent 1/29 (3)
Peripheral artery disease 7/29 (24)
ASA, American Society of Anesthesiologists; 
COPD, chronic obstructive pulmonary disease; 
CVD, cerebrovascular disease, which could be 
transient ischemic attack or cerebrovascular 
accident; GOLD, Global Initiative for Chronic 
Obstructive Lung Disease. Variables are reported as 
number (%).
Characteristics of the patients 
Median age at time of operation was 74 
years (IQR, 71-78 years), and ﬁve patients 
were female. Estimated glomerular ﬁltration 
rate (eGFR) was 75 mL/min/1.73 m2 (IQR, 
58-89 mL/min/1.73 m2). One patient had an 
eGFR of 12 mL/min/1.73 m2 and was dialysis 
dependent preoperatively. Cardiac disease 
included coronary heart disease in eight cases 
and arrhythmia in six cases. All risk factors 
are summarized in Table I. The ASA class 2 
patients were not treated open because of a 
combined TEVAR (n=1), a hostile abdomen 
(n=2), cardiac history favoring EVAR (n=4), 
or clinician’s preference (n=2).
Previous operation characteristics 
Two patients required a fenestrated cuff because of a paraanastomotic AAA at 27 and 36 
months after open AAA repair. Nineteen patients had undergone previous EVAR with an 
infrarenal endograft; 8 were treated with the Anaconda, 10 with the Endurant (Medtronic, 
Santa Rosa, Calif), and 1 with the Aorﬁx (Lombard, Oxfordshire, UK). Four of these endografts 
migrated distally, creating a type IA endoleak in three cases. One case had proximal AAA 
growth. The remaining 14 cases had a type IA endoleak without migration. Time between 
EVAR and fenestrated cuff placement was 41.5 months (IQR, 33-60 months). In six patients, 
the indication was primary repair of a juxtarenal-pararenal aneurysm. In two cases, the 
fenestrated cuff was the distal part of TEVAR for a primary TAA.
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Aneurysm characteristics 
Overall maximum diameter of the AAA was 62 mm (IQR, 44-73 mm). Location of the 
aneurysm was considered short-neck infrarenal (n = 7), juxtarenal (n = 17), suprarenal (n = 
3), or type IV TAA (n = 2). Landing zone diameter was 24 mm (IQR, 23-28 mm). Proximal 
landing zone angle was 8 degrees (IQR, 0-35 degrees), with a maximum angle in one patient 
of 65 degrees. Signiﬁcant aortoiliac tract stenosis or occlusion was present in three patients.
TABLE II. DISTRIBUTION OF FENESTRA-
TIONS IN 29 FENESTRATED ANACONDA 
AORTIC CUFF STENT GRAFTS







SMA+ LRA+RRA 12 36
LRA+RRA 7 14
Total 29 76
CA, Celiac artery; LRA, left renal artery; RRA, 
right renal artery; SMA, superior mesenteric artery.
Implanted endograft speciﬁcs
A total of 76 fenestrations were used, with a 
mean of 2.6 fenestrations per endograft. The 
combination and number of fenestrations 
are summarized in Table II. One case had fe-
nestrations for the celiac artery and the left 
renal artery only. This patient had an occluded 
SMA and was deliberately overstented by the 
aortic cuff. Seventeen endografts had standard 
and 12 had augmented proximal rings. The 
numbers of hooks were 16 four pairs and 13 
three pairs. 
Procedural details and technical success 
All procedures were performed under general anesthesia. In the cases in which bilateral groin 
access was used (n = 20), a cranial approach was added in 14. In all unilateral groin access 
cases (n = 9), cranial access was also used. The total of 23 cranial approaches were brachial 
(n = 7), axillary (n = 7), or subclavian (n = 9). Cutdown groin access was performed in 42 
of the total 49. Operation time was 225 minutes (IQR, 150-260 minutes), blood loss was 200 
mL (IQR, 100-500 mL), and contrast material (iodine 300 mg/mL) volume was 150 mL (IQR, 
92-203 mL). Two patients underwent planned spinal drainage, and no spinal cord injury was 
reported. 
During operation, the feature of collapse and redeployment was used in 9 of 28 cases and 
was unknown in 1 case. In all patients, balloon-expandable covered stents were used for the 
visceral arteries (Atrium ADVANTA V12 [Maquet Holding B.V. & Co KG, Rastatt, Germany; 







Tempe, Ariz; n = 2]). There were seven planned surgical adjunctive procedures in four 
patients. In two patients, an elective TEVAR was done, and in one of them, a left subclavian 
transposition was performed in the same session. In that same patient, an iliac conduit was 
used because of an external iliac artery stenosis. In one patient, bilateral femoral anastomotic 
aneurysm after open repair was present, and bilateral reconstruction was performed. One 
patient had an iliac aneurysm after EVAR, and the original iliac limb was extended to seal the 
iliac aneurysm.
In one patient, a dissection of the distal SMA necessitated a laparotomy with bowel resection 
and iliac-SMA bypass. Another patient needed laparotomy <24 hours after surgery because 
of perforated renal artery, successfully tamponading the bleeding. Consequently, these two 
cases were considered technical failures. In one patient, a renal stent was misplaced between 
the aortic cuff and aortic wall and was irretrievable. The stent was left in place and the renal 
artery was successfully stented with another covered stent. Two patients had an endoleak at 
completion angiography between the original infrarenal endograft and the fenestrated cuff 
and were treated in the same session with a standard Vascutek aortic extension cuff. Conse-
quently, the primary technical success was 86%. With the additional measures, the aneurysm 
was excluded in all patients. All target vessels were successfully stented, and no endoleak was 
noted at ﬁnal angiography, leading to a secondary technical success of 93%. Figure 2 shows 
preoperative and postoperative CTA images of a successfully implanted cuff after previous 
EVAR.
Postoperative results
Seven patients had a complicated course within 30 days postoperatively and four resulted in 
death. One of these patients was treated for a para-anastomotic aneurysm after open repair 
and postoperatively developed a hemorrhagic cerebrovascular accident (CVA). Another 
patient had an ischemic CVA after treatment of a primary AAA. This patient was preopera-
tively known to have cardiac arrhythmia, but a subclavian approach was also used, possibly 
leading to the ischemic CVA. One patient died 3 days after surgery of multiorgan failure after 
dissection of the SMA and subsequent laparotomy. The patient who underwent TEVAR and 
subclavian transposition underwent cholecystectomy at the second postoperative day and 
sigmoidectomy and small bowel resection at the third postoperative day because of ischemia, 
presumably of embolic cause. All branches were open at CTA. He died 11 days postoperati-
vely of multiorgan failure. 
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In the same patient with the misplaced renal stent, an occlusion of the endograft was seen 
on the same day of the operation, possibly because of a small aortic lumen at the level of the 
stented vessels and torsion in the endograft after repositioning. A balloon thrombectomy 
was performed to increase lumen diameter; an additional cuff was placed within the original 
fenestrated cuff. This created a chimney-like appearance where the stents in the fenestrations 
were pushed upward between the two cuffs, maintaining ﬂow to the target organs. The stents 
protruded sufﬁciently within the aortic lumen, and additional extension was not necessary. In 
addition, this patient had a dissection of the external iliac artery treated with a self-expanding 
covered stent. One patient had a groin infection that was treated with conservative measures.
The patient already on dialysis preoperatively required dialysis postoperatively. Two patients 
had a small renal infarction, without stenosis in the corresponding renal artery. One of these 
Figure 2: Preoperative and postoperative computed tomography angiography (CTA) images of the aorta of a patient 
with proximal extension of the aneurysm after previous endovascular aneurysm repair (EVAR). A, On preoperative 
CTA, sealing of the previous Endurant endograft can be seen just below the origin of the superior mesenteric artery 
(SMA). B, On postoperative CTA, sealing of the cuff can be seen between the celiac artery and the SMA. CTA 







patients died of a hemorrhagic CVA, and the other had only minimal decline in eGFR from 
83 to 77 mL/min/1.73 m2. Overall, there was no signiﬁcant difference between preoperative 
and postoperative eGFR (P = .619). 
Follow-up
In the 25 patients alive after the postoperative period, the follow-up was 11 months (IQR, 
3-21 months). In 23 patients, follow-up was beyond 1 month, and CTA was done in all. No 
aneurysm-related deaths were reported. One-year patient survival was 81%±8%, and 2-year 
patient survival was 81%±8% (Figure 3).
Figure 3: Kaplan-Meier curve for overall survival
During follow-up, 3 of 25 patients 
presented with an endoleak. In 
one patient, a type III endoleak 
between the right renal artery 
stent and the fenestration was 
found at 6 months, and a persistent 
type II endoleak was found at 18 
months. The type III endoleak was 
treated with an additional  bal-
loon-expandable  covered stent, 
and the type II endoleak required 
transarterial embolization. A 
laparoscopic infrarenal single tape 
banding was performed at 25 months postoperatively because of continued aneurysm sac 
expansion. One patient had a type III endoleak between the fenestrated cuff and the original 
infrarenal endograft. A full endovascular relining was done at 13 months, with preservati-
on of the stented target vessels. Another patient had continued AAA sac expansion despite 
the fenestrated cuff, without deﬁnite endoleak on CTA. At 20 months, a laparotomy with 
infrarenal neck banding was performed and the AAA sac was explored, identifying two fabric 
failures in the ﬁrst infrarenal endograft. The ﬁrst endograft was left in situ after suturing of 
the fabric tears.
One endograft migration was observed at 9 months postoperatively. It was treated with 
Aptus Heli-FX EndoAnchors (Medtronic) and a proximal extension  with TEVAR. Total en-
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dograft-related reintervention-free 
survival was 75%±9% at 1 year and 
67%±11% at 2 years (Figure 4).
Two patients developed an occlusion 
of the SMA at 15 and 19 months, res-
pectively. Another patient, without a 
stented SMA, had an occlusion at 15 
months postoperatively. In all cases, 
collaterals preserved sufﬁcient vas-
cularization and no treatment was 
necessary. One-year target vessel 
patency was 99%±1%, and 2-year 
target vessel patency was 88%±6% 
(Figure 5).
Decline in eGFR was seen in 
comparing the preoperative (76 mL/
min/m2) vs follow-up (63 mL/min/
m2) values   (P = .044)   but    not 
the    postoperative (77 mL/min/
m2) vs  follow-up (63  mL/min/m2) 
values (P  =   .177).   Median   AAA 
size   remained   stable (P = .946). 
Ten patients had AAA  shrinkage (of 
5 to  32 mm), four had stable AAA 
size, four had a marginal increase in 
AAA-size (1 to 5 mm), and ﬁve had 
an increase of >5 mm in AAA size. 
Figure 4: Kaplan-Meier curve for endograft-related 
reintervention-free survival. Note that one patient had a 
reintervention on the same day as the operation.
Figure 5: Kaplan-Meier curve for target vessel patency. Note that 
one target vessel occluded 1 day postoperatively.
These patients were treated with  a  fenestrated cuff because  of  a  type  IA endoleak after 
prior EVAR. The  mentioned  patient  with the type III and type II endoleak had an AAA sac 
expansion of 30 mm, and  the  mentioned  patient with an endoleak between the cuff and the 
original EVAR had an AAA sac expansion of 6 mm. In three other cases, no explanation for 
the sac expansion (7, 10, and 11 mm, respectively) could be found, and close follow-up was 








This study shows the applicability of the Fenestrated Anaconda cuff in para-anastomotic 
AAA, as salvage after failed EVAR, or in speciﬁc primary complex AAA cases.
The complication rate in our study of 24% is slightly higher than in primary treatment of 
complex  AAAs  with the Fenestrated Anaconda. Primary treatment was shown to have an 
early complication rate of 19% to 24%.20-23 Postoperative complication risk and mortality 
require limitation of the use of the Fenestrated Anaconda cuff to patients in whom open 
repair is not  an option, and careful selection of patients is essential.
Primary infrarenal AAA has a 30-day mortality of approximately 5% in open repair and 1% 
in EVAR.7 The elective open approach for failed EVAR has a 30-day mortality rate of 3%.24 In 
the primary repair of complex AAA, fenestrated EVAR (FEVAR) has similar postoperative 
mortality compared with open repair of 4% but seems favorable in high-risk patients not 
eligible for open repair.25 The postoperative mortality of 14% (4/29) in our study is higher 
than the reported early mortality of 4% to 7%.20-22 A single incident will have a signiﬁcant 
inﬂuence on complication rate because of the small sample size in our study. Nevertheless, the 
frequent use of the cranial approach to cannulate downward-oriented target vessels possibly 
led to one fatal CVA in one patient. FEVAR carries the additional risk of embolization to vital 
organs.26 Reinterventions probably increase this risk, possibly causing multiorgan failure in 
one of the patients. Twenty-one patients had an ASA 3 classiﬁcation, and a high number of 
patients had stroke-related risk factors, such as smoking, hypertension, and cardiac disease 
(Table I).27 The preoperative characteristics possibly inﬂuenced the postoperative mortality.
During follow-up, three patients had an occlusion of the SMA (two stented cases, one 
unstented case), without clinical consequences. The incidence seems  higher  than with 
primary repair, and it was unclear why the SMA became occluded in these cases.22 All these 
cases were treated after EVAR, and the double aortic devices possibly inﬂuence the patient’s 
natural anatomy, consequently leading to occlusion.
There was a statistically signiﬁcant decline of 13 mL/min/1.73 m2 between preoperative 
eGFR and follow-up eGFR, without any clinical consequences. Only one patient had a new 
postoperative stenosis of a renal artery, with a decline in eGFR of 15 mL/min/1.73 m2. In the 
other cases, the cause for eGFR decline was unknown and possibly not device related. The 
risk of declining renal function in FEVAR has been described before, and extra attention is 
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warranted in cases at risk of renal failure.28
The placement of a fenestrated cuff after previous (endovascular) AAA repair or in very 
complex primary cases can technically be more difﬁcult, reﬂected by more fenestrations 
and cranial approaches, compared with regular FEVAR. The operation time and number 
of fenestrations in our study were similar to earlier published data about the Fenestrated 
Anaconda, reﬂecting the experience of the surgeons.20,21
The main difference between the three currently commercially available fenestrated cuffs is 
the maximum possible landing zone angle, depending on the endograft’s design. The circular 
Z-stents from the Zenith fenestrated limit the landing zone angle to 45 degrees, which can 
be increased in the JOTEC E-xtra Design (JOTEC, Hechingen, Germany) to 60 degrees. The 
unsupported graft below separate circular proximal rings allows a landing zone angle of 90 
degrees in the Fenestrated Anaconda. Furthermore, the delivery system of the Fenestrated 
Anaconda allows collapse, redeployment, and cannulation of the target vessels from above, 
without releasing the main device.19 The Zenith fenestrated has proved to be a safe and 
effective option for migrated or type I endoleak EVAR.15 Our study is the ﬁrst to show the 
applicability of the Fenestrated Anaconda cuff, and the results for the JOTEC E-xtra Design 
are still awaited. Choosing a fenestrated cuff should be dependent on the patient’s anatomy 
because of the limited available evidence for either of the fenestrated cuffs.
Several alternatives should be kept in mind for salvage of failed EVAR, such as the use of 
EndoAnchors to appose the endograft against the aortic wall.29,30 The  use of a cuff with 
chimneys or a combination with EndoAnchors.31 The EndoVascular Aneurysm Sealing 
System (Endologix, Irvine, Calif) with chimneys may also be successful in patients with failed 
EVAR.32
Complete relining of the previous EVAR or paraanastomotic AAA with a bifurcated or 
aortouni-iliac endograft is an alternative in certain cases to the aortic cuff and is preferred 
nowadays by multiple clinicians. This could have led to a selection bias in this study. Evidence 
for complete relining with a fenestrated endograft is still limited but shown to be equally 
challenging in one small cohort study.33 More research needs to be conducted to prove the 
feasibility of relining in speciﬁc cases.4,34
Despite great experience in each center with the fenestrated endografts, each center implanted 
one to ﬁve cuffs, and these small numbers per center will result in inexperience with this 







which could have led to a selection bias. Because of the diversity in cases and small sample 
size, our ﬁndings may not be generalizable to all situations in which fenestrated cuffs would 
be applicable.
The duration of follow-up information varied greatly, from the perioperative period to 44 
months postoperatively. Consequently, long-term follow-up data were not available for every 
patient.
Conclusion 
The Fenestrated Anaconda aortic cuff can be used to treat patients with a para-anastomo-
tic aneurysm after open AAA repair, in a complicated course after infrarenal EVAR, and in 
primary complex AAA. The complexity of certain AAA cases is underlined by this study, and 
the Fenestrated Anaconda aortic cuff is an option in  cases in which few treatment options 
are left.
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The Fenestrated Anaconda Cuff Study Group 
In order of the number of included cases; when the number of inclusions is equal, the order 
is alphabetical.
J. Falkensammer, MD, PhD (Wilhelminenspital, Vienna, Austria)
D. Kotelis, MD, PhD (Universitätsklinikum der RWTH Aachen, Aachen, Germany)
S. Mylonas, MD, PhD, and Professor J. Brunkwall, MD, PhD (University Hospital Cologne, 
Köln, Germany)
R.H. Geelkerken, MD, PhD, and R. Meerwaldt, MD, PhD (Medisch Spectrum Twente, 
Enschede, The Netherlands)
A. Giménez-Gaibar, MD, PhD (Parc Taulí Hospital Universitari, Sabadell, Spain)
A. Papaioannou, MD (Evangelisches Krankenhaus Mülheim, Mülheim, Germany)
K. Pﬁster, MD, PhD, and P. Kasprzak, MD, PhD (Universitätsklinikum Regensburg, 
Regensburg, Germany)
M.M.P.J. Reijnen, MD, PhD, and J.W.H.P. Lardenoije, MD, PhD (Rijnstate Hospital, Arnhem, 
The  Netherlands)
R. Williams, MD (Newcastle upon Tyne Hospitals, United Kingdom)
M. Delbridge, MD (Norfolk and Norwich University Hospitals, United Kingdom)
G.F. Fadda, MD, PhD (Ospedale San Francesco, Nuoro, Italy)
R. Martinez, MD, PhD (Hôpital Trousseau Centre Hospitalier Universitaire, Tours, France)
G. Rouhani, MD (Klinikum Höchst, Frankfurt, Germany)
B. Rylski, MD (Universitäts-Herzzentrum Freiburg, Freiburg, Germany)
H.J.M. Verhagen (Erasmus Medical Center, Rotterdam, The Netherlands)
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